Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Savient Pharmaceuticals, a biopharmaceutical company, has appointed David Gionco as its new vice president, CFO and treasurer. Mr Gionco replaces Brian Hayden, who has been terminated as Savient's CFO.
Subscribe to our email newsletter
Mr Gionco has spent more than 18 years in the pharmaceutical industry, including the past three years with Savient where he most recently served as vice president of corporate finance and controller.
Mr Gionco holds a BS in accounting from Fairleigh Dickinson University and an MBA from Rutgers University.
Paul Hamelin, president of Savient, said: “We are pleased to announce David’s appointment. As our current vice president of corporate finance and controller, David will be able to seamlessly step in as CFO.
“Since joining Savient in 2006, David has distinguished himself as a true leader in the financial and operational areas. David’s experience and dedication makes him well-suited to lead our finance and accounting departments.”